Electrochemical and optical methods for detection of cystatin C as a biomarker of kidney disease

被引:0
|
作者
Zhang, Jiakui [1 ]
Ren, Baiping [2 ]
Liu, Jingxuan [3 ]
Li, Hongwu [4 ]
机构
[1] China Med Univ, Affiliated Hosp 4, Dept Surg Oncol, Shenyang 110032, Liaoning, Peoples R China
[2] Shangjing Hosp, Dept Urol, Chifeng 024000, Inner Mongolia, Peoples R China
[3] China Med Univ, Affiliated Hosp 4, Dept Urol, Shenyang 110032, Liaoning, Peoples R China
[4] China Med Univ, Dept Gen Surg, Affiliated Hosp 4, Shenyang 110032, Liaoning, Peoples R China
关键词
Chronic kidney disease; Cystatin C; Biomarker; Electrochemical biosensor; Optical biosensor; GLOMERULAR-FILTRATION-RATE; GAMMA-TRACE; SERUM; MARKER; IMMUNOASSAY; ASSAY; IMMUNOSENSOR; BIOSENSOR; SENSOR; ELISA;
D O I
10.1016/j.cbi.2024.111355
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The kidneys have vital functions in the body, including maintaining homeostasis and blood pressure, controlling water-electrolyte balance, and eliminating metabolic wastes. Early identification of renal dysfunction disease and selection of effective treatment methods reduce mortality in patients. Nowadays, Common indicators of kidney function lack the necessary specificity and sensitivity, but recent studies have reported that cystatin C (CysC) may be an ideal marker for glomerular filtration. CysC, known as a cysteine protease inhibitor, is synthesized by nucleated cells and is easily filtered due to its positive charge and low molecular weight. Also, the synthesis and secretion of CysC is a stable process that is not affected by dietary factors, enhanced protein catabolism, and renal conditions. Various studies have reported that measuring the level of CysC in the body's biological fluids is necessary for the treatment and diagnosis of a wide range of diseases, especially chronic kidney disease (CKD). Despite evidence that positive correlation between the high risk and/or progression of CKD and CysC, it's applied in clinical practice is still rare. Biosensors have been widely developed and researched as an effective method for the pharmaceutical, environmental, and medical fields. Biosensors are designed to create an effective electronic signal commensurate with the concentration of a particular biochemical.Recently, many studies have used biosensor techniques to detect CysC in kidneys and other diseases. In this study, we attempt to examine studies that have used different biosensor techniques for the detect CysC.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] A systematic review assessing the potential use of cystatin c as a biomarker for kidney disease in people living with HIV on antiretroviral therapy
    Hanser, Sidney
    Choshi, Joel
    Mokoena, Haskly
    Mabhida, Sihle E.
    Mchiza, Zandile J. R.
    Moetlediwa, Marakiya T.
    Muvhulawa, Ndivhuwo
    Nkambule, Bongani B.
    Ndwandwe, Duduzile
    Nqebelele, Unati
    Kengne, Andre P.
    Dludla, Phiwayinkosi V.
    FRONTIERS IN MEDICINE, 2024, 11
  • [32] Cystatin C as a risk factor for outcomes in chronic kidney disease
    Menon, Vandana
    Shlipak, Michael G.
    Wang, Xuelei
    Coresh, Josef
    Greene, Tom
    Stevens, Lesley
    Kusek, John W.
    Beck, Gerald J.
    Collins, Allan J.
    Levey, Andrew S.
    Sarnak, Mark J.
    ANNALS OF INTERNAL MEDICINE, 2007, 147 (01) : 19 - 27
  • [33] CYSTATIN C, DIABETIC KIDNEY DISEASE, AND IMPLICATIONS FOR DIABETES MANAGEMENT
    Nadolsky, Karl Z.
    ENDOCRINE PRACTICE, 2017, 23 (02) : 241 - 242
  • [34] Classification of chronic kidney disease: Cystatin C or serum creatinine?
    Modi, Gopesh K.
    NATIONAL MEDICAL JOURNAL OF INDIA, 2014, 27 (02): : 87 - 89
  • [35] THE URINARY CYSTATIN C LEVEL AS A PROGNOSTIC BIOMARKER OF MORTALITY IN PATIENTS WITH ACUTE KIDNEY INJURY
    Park, Moo Young
    Choi, Soo Jung
    Kim, Jin Gook
    Hwang, Seung Duk
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 365 - 366
  • [36] Insufficient performance of serum cystatin C as a biomarker for acute kidney injury of postrenal etiology
    Hasslacher, Julia
    Lehner, Georg F.
    Joannidis, Michael
    INTENSIVE CARE MEDICINE, 2012, 38 (01) : 170 - 171
  • [37] Urine Cystatin C as a Biomarker of Proximal Tubular Function Immediately after Kidney Transplantation
    Hall, Isaac E.
    Koyner, Jay L.
    Doshi, Mona D.
    Marcus, Richard J.
    Parikh, Chirag R.
    AMERICAN JOURNAL OF NEPHROLOGY, 2011, 33 (05) : 407 - 413
  • [38] Cystatin C in acute kidney injury diagnosis: early biomarker or alternative to serum creatinine?
    Lagos-Arevalo, Paola
    Palijan, Ana
    Vertullo, Laura
    Devarajan, Prasad
    Bennett, Michael R.
    Sabbisetti, Venkata
    Bonventre, Joseph V.
    Ma, Qing
    Gottesman, Ronald D.
    Zappitelli, Michael
    PEDIATRIC NEPHROLOGY, 2015, 30 (04) : 665 - 676
  • [39] Cystatin C in acute kidney injury diagnosis: early biomarker or alternative to serum creatinine?
    Paola Lagos-Arevalo
    Ana Palijan
    Laura Vertullo
    Prasad Devarajan
    Michael R. Bennett
    Venkata Sabbisetti
    Joseph V. Bonventre
    Qing Ma
    Ronald D. Gottesman
    Michael Zappitelli
    Pediatric Nephrology, 2015, 30 : 665 - 676
  • [40] Urinary cystatin C levels as a diagnostic and prognostic biomarker in patients with acute kidney injury
    Park, Moo Yong
    Choi, Soo Jeong
    Kim, Jin Kuk
    Hwang, Seung Duk
    Lee, Yong Wha
    NEPHROLOGY, 2013, 18 (04) : 256 - 262